Tvardi Therapeutics investigated for potential securities fraud.

viernes, 21 de noviembre de 2025, 10:18 am ET1 min de lectura
TVRD--

Faruqi & Faruqi is investigating potential claims against Tvardi Therapeutics, Inc. for significant losses in the company's stock or options. Investors who suffered losses are encouraged to contact James (Josh) Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) or click here for additional information.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios